DERIVES DE PYRAZOLE EN TANT QUE MODULATEURS DU CANAL CALCIQUE ACTIVE PAR LA LIBERATION DE CALCIUM ET METHODE DE TRAITEMENT POUR LE CANCER DU POUMON A CELLULES NON PETITES
RHIZEN PHARMACEUTICALS SA;MUTHUPPALANIAPPAN, MEYYAPPAN;VISWANADHA, SRIKANT;VARANASI, KANTHIKIRAN VS;MERIKAPUDI, GAYATRI SWAROOP;VAKKALANKA, SWAROOP KUMAR V. S.
发明人:
MUTHUPPALANIAPPAN, MEYYAPPAN,VISWANADHA, SRIKANT,VARANASI, KANTHIKIRAN VS,MERIKAPUDI, GAYATRI SWAROOP,VAKKALANKA, SWAROOP KUMAR V. S.
申请号：
CA2784277
公开号：
CA2784277C
申请日:
2010.10.07
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
Dislcosed are novel calcium release-activated calcium (CRAC) channelinhibitors, such as(see above formula), methods for preparing them, pharmaceuticalcompositions containing them, and methods of treatment using them. The presentdislcosurealso relates to methods for treating non-small cell lung cancer (NSCLC) withCRACinhibitors, and to methods for identifying therapeutics for treating and ofdiagnosing cancer.
